[1]Yang Y,Takeuchi S,Tsukasaki K,et al.Methylation analysis of the adenomatous polyposis coli(APC) Gene in adult T-cell leukemia/lymphoma[J].Leuk Res,2005,29(1): 47-51.
[2]Zysman M,Saka A,Millar A, et al.Methylation of adenomat-
ous polyposis coli in endometrial carcinoma occurs more frequently in tumors with microsatellite instability phenotype[J].Carcinoma Res,2002,62(13):3663-3666.
[3]Zambrano P, Segura Pacheco B, Perez Cardenas E, et al. A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes[J].BMC Carcinoma,2005,5(1):44-55.
[4]Wiley A,Katsaros D,Chen H,et al. Aberrant promoter meth-
ylation of multiple genes in malignant ovarian tumors and in ovarian tumors with lowmalignant potential[J].Cancer,2006,107(2):299-308.
[5]Makarla PB,Saboorian MH,Ashfaq R,et al.Promoter hyper-
methylation profile of ovarian epithelial neoplasms[J].Clin Cancer Res,2005,11(15):5365-5369 .
[6]Lustig B,Behrens J.The wnt signaling pathway and its role in tumor development[J].J Cancer Res Clin Oncol,2003,129(4):199-221.
[7]Hatle KM,Neveu W,Dienz O,et al. Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression[J].Mol Cell Biol,2007,27(8): 2952-2966.
[8]Collins Y, Dicioccio R, Keitz B, et al. Methylation of death-associated protein kinase in ovarian carcinomas[J].Int J Gynecol Cancer,2006,16(Suppl 1):195-199.
[9]Wei SH,Balch C,Paik HH,et al.Prognostic DNA methylation biomarkers in ovarian cancer[J].Clin Cancer Res,2006,12(9):2788-2794.
[1]李彩云,龚谋春,潘建虎,等.卵巢癌二次探查手术前PET-CT检查的作用及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2013,15(02):141.
.Department of Obstetrics and Gynecology.PET-CT Center7 Hospital of PLA,Hangzhou,Zhejiang 00,et al.LI Cai-yun1,GONG Mou-chun1,PAN Jian-hu2[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(06):141.
[2]朱饮源,姚 军,李 曼.糖原合成酶激酶3β对卵巢癌紫杉醇耐药性的影响及机制研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(01):29.[doi:10.3969/j.issn.1672-271X.2015.01.009]
ZHU Yin-yuan,YAO Jun,LI Man..The effects of GSK-3β on paclitaxel chemoresistance of ovarian cancer cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(06):29.[doi:10.3969/j.issn.1672-271X.2015.01.009]
[3]陈 慧,张 兰,郭以河,等.Eag1钾离子通道在卵巢癌组织中的表达及意义[J].医学研究与战创伤救治(原医学研究生学报),2016,18(01):17.[doi:10.3969/j.issn.1672-271X.2016.01.005]
CHEN Hui,ZHANG Lan,GUO Yi-he,et al.Expression and significance ofether à go-go 1 channels in human ovarian cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(06):17.[doi:10.3969/j.issn.1672-271X.2016.01.005]
[4]赵昊云,张承,杨林东综述,等.卵巢癌的脑转移诊疗进展[J].医学研究与战创伤救治(原医学研究生学报),2016,18(02):180.[doi:10.3969/j.issn.1672-271X.2016.02.022]
[5]洪丽君,曾清芳,卢昆林,等.高尔基体磷蛋白3在卵巢癌中的表达及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2017,19(04):357.[doi:10.3969/j.issn.1672-271X.2017.04.006]
HONG Li-jun,ZENG Qing-fang,LU Kun-lin,et al.Expression and clinical significance of Golgi phosphoprotein 3 in ovarian cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(06):357.[doi:10.3969/j.issn.1672-271X.2017.04.006]
[6]杨帆,谢树红综述,黄惠娟审校.卵巢癌在代谢组学中的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):160.[doi:10.3969/j.issn.1672-271X.2018.02.012]
[7]谢树红,黄惠娟,许玉黎,等.橄榄苦苷对体外卵巢癌SKOV3细胞增殖的影响[J].医学研究与战创伤救治(原医学研究生学报),2018,20(04):361.[doi:10.3969/j.issn.1672-271X.2018.04.008]
XIE Shu-hong,HUANG Hui-juan,XU Yu-li,et al.Effects ofoleuropein on proliferation of ovarian cancer SKOV3 cells in vitro[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(06):361.[doi:10.3969/j.issn.1672-271X.2018.04.008]
[8]许玉黎,黄惠娟,谢树红,等.橄榄苦苷对卵巢癌裸鼠皮下移植瘤抑瘤作用的研究[J].医学研究与战创伤救治(原医学研究生学报),2018,20(06):561.[doi:10.3969/j.issn.1672-271X.2018.06.001]
XU Yu-li,HUANG Hui-juan,XIE Shu-hong,et al.Study on antitumor effects of oleuropein on ovarian cancer subcutaneous transplanted tumor in nude mice[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(06):561.[doi:10.3969/j.issn.1672-271X.2018.06.001]
[9]陈娟,刘传丽,陈艳思,等.IL-17A在卵巢癌中的表达水平及潜在机制的生物信息学分析[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):25.[doi:10.3969/j.issn.1672-271X.2020.01.006]
CHENJuan,LIUChuan-li,CHENYan-si,et al.The expression level of IL-17A in ovarian cancer and the bioinformatics analysis of potential mechanism[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(06):25.[doi:10.3969/j.issn.1672-271X.2020.01.006]